← stocks-llm New chat

Insight Molecular Diagnostics Inc. (IMDX) — insider trading

Health Care · NASDAQ

Insight Molecular Diagnostics Inc. (IMDX) has 29 reported SEC Form 4 insider transactions in our data, including 14 open-market purchases among the most recent 29 (latest 2026-07-01).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-07-01 Arno Andrew Director Shares withheld for taxes / exercise cost 12,100 $5.69 $68.8K Form 4
2026-07-01 Last Andrew J. Director Shares withheld for taxes / exercise cost 7,700 $5.69 $43.8K Form 4
2026-07-01 SILVERMAN LOU Director Shares withheld for taxes / exercise cost 7,700 $5.69 $43.8K Form 4
2026-06-11 Arno Andrew Director Grant / award / vesting 32,331 $0.00 $0 Form 4
2026-06-11 Last Andrew J. Director Grant / award / vesting 26,943 $0.00 $0 Form 4
2026-06-11 SILVERMAN LOU Director Grant / award / vesting 26,943 $0.00 $0 Form 4
2026-04-27 BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; Bradsher Neal C 10% owner Open-market purchase 0 $0.00 $0 Form 4
2026-04-27 BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; Bradsher Neal C 10% owner Open-market purchase 250,923 $3.64 $913.1K Form 4
2026-04-24 BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; Bradsher Neal C 10% owner Open-market purchase 0 $0.00 $0 Form 4
2026-04-24 BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; Bradsher Neal C 10% owner Open-market purchase 38,880 $3.53 $137.1K Form 4
2026-04-23 BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; Bradsher Neal C 10% owner Open-market purchase 0 $0.00 $0 Form 4
2026-04-23 BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; Bradsher Neal C 10% owner Open-market purchase 280,381 $3.50 $982.0K Form 4
2026-04-20 BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; Bradsher Neal C 10% owner Open-market purchase 0 $0.00 $0 Form 4
2026-04-20 BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; Bradsher Neal C 10% owner Open-market purchase 40,690 $3.88 $158.0K Form 4
2026-04-17 BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; Bradsher Neal C 10% owner Open-market purchase 0 $0.00 $0 Form 4
2026-04-17 BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; Bradsher Neal C 10% owner Open-market purchase 40,114 $3.57 $143.3K Form 4
2026-04-16 BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; Bradsher Neal C 10% owner Open-market purchase 0 $0.00 $0 Form 4
2026-04-16 BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; Bradsher Neal C 10% owner Open-market purchase 102,057 $3.45 $351.7K Form 4
2026-03-26 Riggs Josh Director, Officer (CEO and President) Option exercise / conversion (derivative) 47,170 $0.00 $0 Form 4
2026-03-26 Riggs Josh Director, Officer (CEO and President) Shares withheld for taxes / exercise cost 12,310 $4.11 $50.6K Form 4
2026-03-26 Riggs Josh Director, Officer (CEO and President) Option exercise / conversion 47,170 Form 4
2026-03-26 Liu James Yang Officer (VP ACCT, Cntlr, Treasurer, PAO) Option exercise / conversion (derivative) 6,289 $0.00 $0 Form 4
2026-03-26 Liu James Yang Officer (VP ACCT, Cntlr, Treasurer, PAO) Shares withheld for taxes / exercise cost 2,578 $4.11 $10.6K Form 4
2026-03-26 Liu James Yang Officer (VP ACCT, Cntlr, Treasurer, PAO) Option exercise / conversion 6,289 Form 4
2026-03-26 James Andrea S. Officer (Chief Financial Officer) Option exercise / conversion (derivative) 28,302 $0.00 $0 Form 4
2026-03-26 James Andrea S. Officer (Chief Financial Officer) Shares withheld for taxes / exercise cost 11,298 $4.11 $46.4K Form 4
2026-03-26 James Andrea S. Officer (Chief Financial Officer) Option exercise / conversion 28,302 Form 4
2026-02-10 BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; Bradsher Neal C 10% owner Open-market purchase 0 $0.00 $0 Form 4
2026-02-10 BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; Bradsher Neal C 10% owner Open-market purchase 521,739 $5.75 $3.00M Form 4

Ask the chat about IMDX's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: Insight Molecular Diagnostics Inc. (IMDX).

Last updated 2026-07-01 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.